Premier Biotech Expands Service Offering with Desert Tox Acquisition
Summary
CLEVELAND & DALLAS--(BUSINESS WIRE)--Align Capital Partners’ (“ACP”) toxicology testing solutions provider Premier Biotech (“Premier” or the “Company”) has acquired Desert Tox, LLC (“Desert Tox”), a provider of Substance Abuse and Mental Health Services Administration (“SAMHSA”) certified laboratory testing services. We believe our combined expertise will position us in an emerging oral fluids market to deliver testing solutions with unmatched value and enable customers to make timely and informed decisions for their compliance and safety needs,” said Grommes. “This is a highly strategic acquisition for us given Desert Tox’s SAMHSA certification, long-standing customer relationships and strong reputation for rapid turn-around times. While enhancing our workplace service offering, this acquisition reflects our commitment to building a complete solutions set to better serve our growing customer base. The Company’s integrated offering is utilized in workplace (pre-employment and post-employment), government (child and family services, probation, parole, corrections, law enforcement and DOT) and healthcare settings.